AdaptHealth (AHCO) EBIT (2018 - 2026)

AdaptHealth has reported EBIT for 9 years, with the latest figure at -$137.8 million in Q2 2026.

• On a quarterly basis, EBIT fell 309.76% year-over-year to -$137.8 million in Q2 2026; TTM through Jun 2026 was -$143.9 million, a 157.54% decrease from a year earlier, with the FY2025 full-year figure at $90.9 million, down 65.54% from the prior year.
• EBIT was -$137.8 million for Q2 2026 at AdaptHealth, down from $5.5 million in the prior quarter.
• The five-year high for EBIT was $97.7 million in Q4 2024, with the low at -$461.0 million in Q3 2023.
• Average EBIT over 5 years is -$11.1 million, with a median of $51.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: EBIT soared 234.56% in 2022, then plunged 970.72% in 2023.
• Over 5 years, EBIT stood at $26.7 million in 2022, then tumbled by 914.77% to -$217.8 million in 2023, then jumped by 144.84% to $97.7 million in 2024, then tumbled by 175.03% to -$73.3 million in 2025, then sank by 88.05% to -$137.8 million in 2026.
• The last three EBIT figures came in at -$137.8 million (Q2 2026), $5.5 million (Q1 2026), and -$73.3 million (Q4 2025), per Business Quant data.